About
4.64CAD+0.05 +1.09%
Closed • Updated at 23:37 GMT+00:00Market Cap$105.28M
Volume10.1K
Beta0.60
RSI52.74
Gross Margin41.97%
Hls Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
HLS Therapeutics Announces Q1 2026 Financial Results
May 1 2026
HLS Therapeutics to Host Q1 2026 Financial Results Conference Call
Apr 14 2026
HLS Therapeutics to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Mar 12 2026
HLS Therapeutics Announces Fiscal 2025 Financial Results
Mar 5 2026
HLS Therapeutics Announces NILEMDOTM (bempedoic acid) is now available in Canada for the Reduction of LDL-Cholesterol in Patients at Risk of Cardiovascular Disease
Community Chat
Ask AI
Try asking
Translate